| The Akt/mTOR pathway in cancer stem/progenitor cells is a potential therapeutic target for glioblastoma and neuroblastoma HF Bahmad, TH Mouhieddine, RM Chalhoub, S Assi, T Araji, F Chamaa, ... Oncotarget 9 (71), 33549, 2018 | 56 | 2018 |
| Assessing Radiosensitivity of Bladder Cancer in vitro: A 2D vs. 3D Approach L Bodgi, HF Bahmad, T Araji, J Al Choboq, J Bou-Gharios, K Cheaito, ... Frontiers in oncology 9, 153, 2019 | 30 | 2019 |
| Tideglusib attenuates growth of neuroblastoma cancer stem/progenitor cells in vitro and in vivo by specifically targeting GSK-3β HF Bahmad, RM Chalhoub, H Harati, J Bou-Gharios, S Assi, F Ballout, ... Pharmacological Reports 73, 211-226, 2021 | 24 | 2021 |
| The potential use of tideglusib as an adjuvant radio-therapeutic treatment for glioblastoma multiforme cancer stem-like cells J Bou-Gharios, S Assi, HF Bahmad, H Kharroubi, T Araji, RM Chalhoub, ... Pharmacological Reports 73, 227-239, 2021 | 17 | 2021 |
| Recognizing who is at risk for postpartum hemorrhage: targeting anemic women and scoring systems for clinical use H Faysal, T Araji, HK Ahmadzia American journal of obstetrics & gynecology MFM 5 (2), 100745, 2023 | 9 | 2023 |
| Risk of thromboembolic events in non-hospitalized COVID-19 patients: A systematic review GP Massoud, DH Hazimeh, G Amin, W Mekary, J Khabsa, T Araji, S Fares, ... European Journal of Pharmacology 941, 175501, 2023 | 5 | 2023 |
| Knowledge, attitude, and beliefs of medication use in pregnancy in an urban tertiary care center J Kazma, T Araji, A Khilnani, J van den Anker, HK Ahmadzia The Journal of Clinical Pharmacology 62, S30-S35, 2022 | 3 | 2022 |
| Advances in Minimally Invasive Gynecologic Reproductive Surgery B Rizk, M Abuzeid, I Alkatout, L Mettler CRC Press, 2021 | 3 | 2021 |
| Cancerona: challenges of cancer management in times of COVID-19 pandemic F Ballout, R Daouk, J Azar, M Timonian, T Araji, HF Bahmad, ... SN Comprehensive Clinical Medicine 2, 2005-2014, 2020 | 3 | 2020 |
| Radiation treatment timing and dose delivery: effects on bladder cancer cells in 3D in vitro culture L Bodgi, J Al-Choboq, T Araji, J Bou-Gharios, J Azzi, R Challita, ... Radiation 2 (4), 318-337, 2022 | 2 | 2022 |
| Preoperative MELD score predicts adverse outcomes following gastrectomy: An ACS NSQIP analysis HH Khachfe, TZ Araji, H Nassereldine, R El-Asmar, HA Baydoun, ... The American Journal of Surgery 224 (1), 501-505, 2022 | 2 | 2022 |
| Specific inhibition of GSK-3β by Tideglusib: potential therapeutic target for neuroblastoma cancer stem cells HF Bahmad, RM Chalhoub, H Harati, J Bou-Gharios, F Ballout, A Monzer, ... bioRxiv, 2020.02. 18.953596, 2020 | 2 | 2020 |
| Recurrent Closed Loop Bowel Obstruction in Third Trimester of Pregnancy: Case Report and Review of Literature T Araji, S Wang, N Kandalaft, J Estroff, HK Ahmadzia SN Comprehensive Clinical Medicine 4 (1), 178, 2022 | 1 | 2022 |
| Evaluating The Role of ChatGPT as a Study Aid in Medical Education in Surgery T Araji, AD Brooks Journal of Surgical Education 81 (5), 753-757, 2024 | | 2024 |
| A Narrative Review on Intraoperative Adverse Events: Risks, Prevention, and Mitigation N Kawa, T Araji, H Kaafarani, SW Adra Journal of Surgical Research 295, 468-476, 2024 | | 2024 |
| Impact of COVID-19 Pandemic Surge on Surgical Outcomes: A Retrospective Study T Yoshida, R Chude-Sokei, T Araji, S Adra The American Surgeon™, 00031348241227213, 2024 | | 2024 |
| MO-0723 Previous Irradiation Impairs the DNA DSB Repair System in Sheep Lung-Derived Epithelial Cells. L Bodgi, J Al-Choboq, J Azzi, JB Gharios, C Feghaly, R Challita, HB Hadir, ... Radiotherapy and Oncology 182, S591-S592, 2023 | | 2023 |
| Radiation Treatment Timing and Dose Delivery: Effects on Bladder Cancer Cells in 3D in Vitro Culture. Radiation 2022, 2, 318–337 L Bodgi, J Al-Choboq, T Araji, J Bou-Gharios, J Azzi, R Challita, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
| Robotic Myomectomy T Araji, B Rizk, MA Borahay Advances in Minimally Invasive Gynecologic Reproductive Surgery, 101-109, 2021 | | 2021 |
| Correction to: The potential use of tideglusib as an adjuvant radio-therapeutic treatment for glioblastoma multiforme cancer stem-like cells J Bou-Gharios, S Assi, HF Bahmad, H Kharroubi, T Araji, RM Chalhoub, ... Pharmacological reports: PR 73 (1), 316, 2021 | | 2021 |
